LAS VEGAS , Nov. 2, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine through education and research, today announced results from the Late-Breaking Clinical Trials presented at The VEINS 2025 conference, held at Wynn Las Vegas.

Late-Breaking Clinical Trial results were unveiled during sessions on Saturday and Sunday, November 1 and 2, showcasing new data that advance the understanding and treatment of venous disease.

The VEINS ( V enous E ndovascular IN terventional S trategies) is a leading venous education symposium that brings together an international, multispecialty faculty to share the latest research, clinical data, and techniques in venous intervention. The program features expert presenta

See Full Page